Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Jynneos Generic Name & Formulations
Legal Class
Rx
General Description
Smallpox and Monkeypox vaccine, live, non-replicating; contains 0.5–3.95×108 infectious units of MVA-BN live virus; per 0.5mL dose; susp for SC inj; preservative-free.
How Supplied
Single-dose vials—20
Manufacturer
Generic Availability
NO
Jynneos Indications
Indications
Prevention of smallpox and monkeypox disease in adults determined to be at high risk for smallpox or monkeypox infection.
Jynneos Dosage and Administration
Adult
Give by SC inj (preferably into deltoid). ≥18yrs: 2 doses (0.5mL each) given 4 weeks apart.
Children
<18yrs: not established.
Jynneos Contraindications
Not Applicable
Jynneos Boxed Warnings
Not Applicable
Jynneos Warnings/Precautions
Warnings/Precautions
Have appropriate medical treatment available to manage possible anaphylactic reactions. Immunocompromised. Vaccination may not protect all recipients. Pregnancy. Nursing mothers.
Jynneos Pharmacokinetics
See Literature
Jynneos Interactions
Jynneos Adverse Reactions
Adverse Reactions
Inj site reactions (eg, pain, swelling, redness, induration, itching), muscle pain, headache, fatigue, nausea, chills; severe allergic reactions.
Jynneos Clinical Trials
See Literature
Jynneos Note
Not Applicable
Jynneos Patient Counseling
See Literature
